Cargando…
A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
Background: Clear cell renal cell carcinoma (ccRCC) is the most common subtype in renal cell carcinoma with relatively poor clinical outcomes DNA damage repair genes (DDRGs) as potential biomarkers are rarely reported in predicting immunotherapy response and clinical prognosis for ccRCC. Methods: RN...
Autores principales: | Peng, Linjie, Liang, Jiaming, Wang, Qi, Chen, Guodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152249/ https://www.ncbi.nlm.nih.gov/pubmed/35656315 http://dx.doi.org/10.3389/fgene.2022.798846 |
Ejemplares similares
-
The Clinical Significance of DNA Damage Repair Signatures in Clear Cell Renal Cell Carcinoma
por: Guo, Ergang, et al.
Publicado: (2021) -
EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022) -
The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023) -
An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
por: Li, Jiaying, et al.
Publicado: (2022) -
The cuproptosis related genes signature predicts the prognosis and correlates with the immune status of clear cell renal cell carcinoma
por: Sun, Peng, et al.
Publicado: (2022)